Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIGITALX LIMITED Director's Dealing 2018

Dec 12, 2018

64762_rns_2018-12-12_958198ee-6575-42ad-aa9f-301326cb889e.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity DigitalX Limited
ABN 59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Peter Irwin Rubinstein
Date of last notice 21 September 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Irwin Biotech Nominees Pty Ltd ATF BIOA Trust. Peter
Irwin Rubinstein is the sole director and shareholder of
Irwin Biotech Nominees Pty Ltd and a beneficiary of
BIOA Trust.
Date of change 10 December 2018
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change Direct
617,284 Subscription Options exercisable at $0.0324
each on or before 1 September 2020
Indirect
13,266,296 Fully Paid Ordinary Shares1
3,000,000 Fully Paid Ordinary Shares2
7,000,000 Fully Paid Ordinary Shares3
3,400,000 Incentive Options exercisable at $0.0324
each on or before 18 September 20201
1. Held by Irwin Biotech Nominees Pty Ltd ATF BIOA Trust.
2. Held by RIP Opportunities Pty Ltd ATF PIR Super Fund.
3. Held by ValueAdmin.Com Pty Ltd.
Class Unlisted Options exercisable at $0.22 each on or
before 10 December 2023.
Unlisted Options exercisable at $0.25 each on or
before 10 December 2023.
Unlisted Options exercisable at $0.30 each on or
before 10 December 2023.
Number acquired 1,000,000 Unlisted Options exercisable at $0.22 each
on or before 10 December 2023.
1,500,000 Unlisted Options exercisable at $0.25 each
on or before 10 December 2023.
2,000,000 Unlisted Options exercisable at $0.30 each
on or before the date 10 December 2023.
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Nil cash consideration. Estimated total value of
$332,000, as detailed in the Notice of Meeting dated 3
October 2018.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change Direct
617,284 Subscription Options exercisable at $0.0324
each on or before 1 September 2020
Indirect
13,266,296 Fully Paid Ordinary Shares1
3,000,000 Fully Paid Ordinary Shares2
7,000,000 Fully Paid Ordinary Shares3
3,400,000 Incentive Options exercisable at $0.0324
each on or before 18 September 20201
1,000,000 Unlisted Options exercisable at $0.22 each
on or before 10 December 20231
1,500,000 Unlisted Options exercisable at $0.25 each
on or before 10 December 20231
2,000,000 Unlisted Options exercisable at $0.30 each
on or before the date 10 December 20231
1. Held by Irwin Biotech Nominees Pty Ltd ATF BIOA Trust.
2. Held by RIP Opportunities Pty Ltd ATF PIR Super Fund.
3. Held by ValueAdmin.Com Pty Ltd.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Issue of Unlisted Options as a long-term incentive, as
approved by Shareholders on 22 November 2018.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
If prior written clearance was provided, on what date was this
provided?
  • See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity DigitalX Limited
ABN 59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Leigh Daniel Travers
Date of last notice 5 July 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
N/A
Date of change 10 December 2018
No. of securities held prior to change Direct
2,561,111 Fully Paid Ordinary Shares
Indirect
1,900,000 Fully Paid Ordinary Shares1
1Held by Leethal Pty Ltd, an entity associated with Mr
Travers.
Class Performance Rights, subject to performance-based
vesting conditions as detailed in the Notice of Meeting
dated 3 October 2018, an expiring 10 December 2023.
Number acquired 9,000,000
Number disposed Nil
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Nil cash consideration
No. of securities held after change Direct
2,561,111 Fully Paid Ordinary Shares
9,000,000 Performance Rights, subject to performance-
based vesting conditions, an expiring 10 December
2023.
Indirect
1,900,000 Fully Paid Ordinary Shares1
1Held by Leethal Pty Ltd, an entity associated with Mr
Travers.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Issue of Performance Rights, as approved by
shareholders on 22 November 2018.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
If prior written clearance was provided, on what date was this
provided?
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity DigitalX Limited
ABN 59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Xue Samuel Lee
Date of last notice 18 September 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
The options are held by Blockchain Global Ltd, a
Company in which Mr Lee is a Director.
Date of change 10 December 2018
No. of securities held prior to change 10,096,296 Fully Paid Ordinary Shares1
1,203,704 Subscription Options exercisable at $0.0324
each on or before 8 September 20201
1,400,000 Convertible Note Options exercisable at
$0.0324 each on or before 8 September 20191
2,800,000 Incentive Options exercisable at $0.0324
each on or before 18 September 20201
1.
Held by Mars Capital Australia Pty Ltd atf Mars
Family Trust. Xue Samuel Lee the appointor of the
Mars Family Trust.
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class Unlisted Options exercisable at $0.22 each on or
before 10 December 2023
Unlisted Options exercisable at $0.25 each on or
before 10 December 2023
Unlisted Options exercisable at $0.30 each on or
before 10 December 2023
Number acquired 1,000,000 Unlisted Options exercisable at $0.22 each
on or before 10 December 2023
1,500,000 Unlisted Options exercisable at $0.25 each
on or before 10 December 2023
2,000,000 Unlisted Options exercisable at $0.30 each
on or before 10 December 2023
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Nil cash consideration. Estimated total value of
$332,000, as detailed in the Notice of Meeting dated 3
October 2018.
No. of securities held after change 10,096,296 Fully Paid Ordinary Shares1
1,203,704 Subscription Options exercisable at $0.0324
each on or before 8 September 20201
1,400,000 Convertible Note Options exercisable at
$0.0324 each on or before 8 September 20191
2,800,000 Incentive Options exercisable at $0.0324
each on or before 18 September 20201
1,000,000 Unlisted Options exercisable at $0.22 each
on or before 10 December 20232
1,500,000 Unlisted Options exercisable at $0.25 each
on or before 10 December 20232
2,000,000 Unlisted Options exercisable at $0.30 each
on or before 10 December 20232
1.
Held by Mars Capital Australia Pty Ltd atf Mars
Family Trust. Xue Samuel Lee the appointor of the
Mars Family Trust.
2.
Held by Blockchain Global Ltd, a Company in
which Mr Lee is a Director.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Issue of Unlisted Options as a long-term incentive, as
approved by Shareholders on 22 November 2018.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
If prior written clearance was provided, on what date was this
provided?
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3